FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents an anti-inflammatory medicinal agent for intranasal application in the form of an aqueous solution in therapy of post-inflammatory complications, containing 100.0 ml of water: 0.001–0.500 g of glycosylated polypeptides recovered from fresh, frozen or dried insides of Strongylocentrotus droebachiensis sea urchins with molecular weight 5.5–7.0 kDa, 0.05–0.20 g of bioadhesive component-polycarbophil, 1.0–2.5 g of glycerin, 0.025–0.15 g of disodium edetate dihydrate, 0.005–0.02 g of benzalkonium chloride and sodium hydroxide solution, providing pH 6–7.
EFFECT: invention provides storage-stable and non-toxic aqueous glycosylated polypeptides for intranasal application, as well as an extended range of anti-inflammatory agents used in therapy of post-inflammatory complications.
6 cl, 7 ex, 2 tbl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING ANTI-INFLAMMATORY AND ANTIALLERGIC ACTION | 2012 |
|
RU2488402C1 |
METHOD FOR PRODUCING PIGMENT COMPLEX OF BISNAPHTHAZARIN | 2014 |
|
RU2545692C1 |
METHOD FOR PRODUCING GLYCOLISED POLYPEPTIDE AGENT | 2014 |
|
RU2545703C1 |
PEPTIDE, AMINO ACID AND PHOSPHOLIPID RICH AGENT | 2012 |
|
RU2481119C1 |
COMPLEX OF BIOLOGICALLY ACTIVE SUBSTANCES FOR TREATING AND PREVENTING CARDIOVASCULAR DISEASES | 2013 |
|
RU2520695C1 |
MEDICATION FOR PREVENTION AND TREATMENT OF ANDROLOGICAL DISEASES AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2519226C1 |
AGENT POSSESSING ANTI-INFLAMMATORY ACTION | 2011 |
|
RU2483741C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTI-INFLAMMATORY, IMMUNOTROPIC, ANTIALLERGIC AND WOUND HEALING ACTION | 2011 |
|
RU2464993C1 |
BIS-NAPHTHAZARIN BASED AGENT AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2669374C2 |
PHARMACEUTICAL KETOROLAC-BASED COMPOSITION IN FORM OF NASAL SPRAY AND METHOD FOR PREPARATION THEREOF | 2015 |
|
RU2611659C1 |
Authors
Dates
2020-01-27—Published
2019-05-16—Filed